![](/assets/images/picto-drapeau-france-3a76576a5d60a512053b4612ab58dae5.png)
4. Benefit/risk balance of nanoparticle-based drugs
4.1 Concept of benefit/risk balance
As mentioned in the 2 section of this article, a drug can be formulated in a nanoparticle (encapsulation) or be the nanoparticle itself. For example, the aim is to:
improve or control bioavailability
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-286623ed91fa802ce039246e516e5852.png)
The Ultimate Scientific and Technical Reference
This article is included in
Nanosciences and nanotechnologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Benefit/risk balance of nanoparticle-based drugs
Bibliography
Standards and norms
- Nanotechnologies, guidance on physicochemical characterization of engineered nanoscale materials for toxicological assessment. - ISO/TR-13014 :2012 - 2012
- Nanotechnologies – Measurements Technique Matrix for the Characterization of Nano-Objects. ISO. - ISO/TR-18196 :2016 - 2016
- Nanotechnologies – Terminology and definitions for nano-objects, nanoparticle, nanofibre and nanoplate. - ISO/TS - 2008
- Particle...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
![](/assets/images/logo-eti-286623ed91fa802ce039246e516e5852.png)
The Ultimate Scientific and Technical Reference